One Stop Shop for All Your Market Research Reports

Asia-Pacific Anticoagulants Market by Manufacturers, Regions, Type and Application, Forecast to 2022

Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment. Scope of the Report: This report focuses on the Anticoagulants in Asia-Pacific market, especially in China, Japan, Korea, Taiwan, Southeast Asia, India and Australia. This report categorizes the market based on manufacturers, countries/Regions, type and application. Market Segment by Manufacturers, this report covers Sanofi Bayer Boehringer Ingelheim Johnson & Johnson Genentech (Roche) AstraZeneca Bristol-Myers Squibb Aspen Lilly Otsuka Pfizer Daiichi Sankyo The Medicines Company Market Segment by Countries, covering China Japan Korea Taiwan Southeast Asia India Australia Market Segment by Type, covers Platelet aggregation inhibitors (PAI) Low-molecular-weight Heparin (LMWH) Direct thrombin inhibitor (DTI) Direct factor Xa inhibitors (DFXa) Vitamin K antagonists (VKA) Others Market Segment by Applications, can be divided into VTE ACS/MI AF Other There are 19 Chapters to deeply display the Asia-Pacific Anticoagulants market. Chapter 1, to describe Anticoagulants Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Anticoagulants, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017; Chapter 4, to show the Asia-Pacific market by countries, covering China, Japan, Korea, Southeast Asia, Taiwan, India and Australia, with sales, price, revenue and market share of Anticoagulants, for each country, from 2012 to 2017; Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017; Chapter 7, 8, 9, 10, 11, 12 and 13 to analyze the key countries by manufacturers, Type and Application,covering China,Japan,Korea,Southeast Asia, Taiwan, India and Australia,with sales,revenue and market share by manufacturers,types and application; Chapter 14, Anticoagulants market forecast, by countries, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022; Chapter 15, to analyze the manufacturing cost, key raw materials and manufacturing process etc. Chapter 16, to analyze the industrial chain, sourcing strategy and downstream end users (buyers); Chapter 17, to describe sales channel, distributors, traders, dealers etc. Chapter 18 and 19, to describe the research findings and conclusion, appendix, methodology and data source
Table of Contents 1 Market Overview 1.1 Anticoagulants Introduction 1.2 Market Analysis by Type 1.2.1 Platelet aggregation inhibitors (PAI) 1.2.2 Low-molecular-weight Heparin (LMWH) 1.2.3 Direct thrombin inhibitor (DTI) 1.2.4 Direct factor Xa inhibitors (DFXa) 1.2.5 Vitamin K antagonists (VKA) 1.2.6 Others 1.3 Market Analysis b
Inquiry Before Buying

Request Sample

Share This Report

Our Clients

Payment Mode
Single User US $ 4480
Corporate User US $8960
About this Report
Report ID 145488
Category
  • Healthcare
Published on 29-Jun
Number of Pages 115
Publisher Name Global Info Research
Editor Rating
★★★★★
★★★★★
(23)